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Functionalization of gold nanostars with poly(ethylene glycol) (PEG) 
The thiolated and carboxylated poly(ethylene glycol) (PEG) spacer was attached by one-step 
ligand exchange (the citrate groups on the surface of gold nanostars were replaced by the thiol 
groups of the PEG molecules). Briefly, 50 mM of HEPES-buffered gold nanostars were mixed 
with 1 mg of a commercial hetero-functional PEG (α-mercapto-ω-carboxy PEG solution, HS–
C2H4–CONH–PEG–O–C3H6–COOH, MW. 5000 Da, Sigma). PEG excess was removed by 
centrifugation (20.000 ×g, 30 min, 4 ºC) and quantified by the Ellman’s Assay. The excess of 
thiolated chains in the supernatant was quantified by interpolating a calibration curve set by 
reacting 200 μL of PEG solution in 100 μL of phosphate buffer (0.5 M, pH 7) with 7 μL 5,5’-
dithio-bis(2-nitrobenzoic) acid (DTNB, 5 mg/mL) in phosphate buffer (0.5 M, pH 7) and 
measuring the absorbance at 412 nm (Figure S1a) after 10 minutes’ reaction.  
The linear range for the PEG chain (Figure S1b) obtained by this method is 0-0.1 mg/mL (Abs at 
412nm = 6.9016×[PEG, mg/mL] + 0.0536).  
 
Figure S1. (a) Absorbance spectra of DTNB after reaction with increasing amounts (0-0.1 mg/mL) 
of thiolated PEG. (b) Standard calibration curve for PEG chains, whose concentration can be 
calculated via the following equation: Abs at 412nm = 6.8655×[PEG, mg/mL] + 0.0573, 
R2=0.9989.  
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Functionalization of gold nanostars with Mitoxantrone (MTX) 
 
The carboxylated PEG spacer previously functionalized on the surface of gold nanostars provides 
the anchoring moieties for the covalent binding of amine-containing molecules like the MTX 
through carbodiimide chemistry (EDC/NHS coupling). The MTX was coupled to the previously 
synthesized PEG-gold nanostars by a carbodiimide chemistry assisted by N-hydroxisuccinimide 
(EDC/NHS coupling reaction) between the carboxylated PEG terminal and the two primary amine 
groups of the MTX. Briefly, 50 nM of HEPES-buffered PEG-gold nanostars, 9.8 mg/mL N-
hydroxysulfosuccinimide (sulfo-NHS, Sigma) and 2500 μg/mL EDC (1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide, Sigma) were incubated in 10 mM MES (2-(N-
morpholino)ethanesulfonic acid, Sigma) at pH 6.2 and allowed to react for 30 minutes to activate 
the carboxylic groups on PEG molecules. Then, activated PEG-gold nanostars were washed once 
with 10 mM MES (pH 6.2) and used immediately. MTX was added to the mixture at a final 
concentration of 30 µM and allowed to react for 16 hours at 25 ºC. The MTX-PEG-gold nanostars 
were centrifuged at 20.000× g for 30 min at 4 ºC and washed three times with Mili-Q water. MTX 
excess was removed by centrifugation (20.000 ×g, 30 min, 4 ºC) and quantified by measuring the 
fluorescence of the MTX in solution (emission maximum at 596 nm). The linear range for the 
MTX (Figure S2) obtained by this method is 0-50 µM (Emission at 596nm = 1.3701×[MTX, µM] 
+ 1.4221, R2=0.9962).  
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Figure S2. (a) Emission spectra of increasing concentrations of Mitoxantrone (MTX). (b) 
Standard addition calibration curve prepared with known concentrations of MTX and prepared by 
calculating the total area under the curve (AUC) of the emission spectra on (a). All experiments 
were done in triplicate and errors reported as standard deviation (s.d.). 
 
 
Table S1. Quantification of PEG and MTX moles per particle for bare, PEG and MTX nanostars. 
Formulation PEG mol per particle MTX mol per particle 
Bare nanostars NA NA 
PEG-nanostars 589.8±10.5 NA 
MTX-nanostars 589.8±10.5 102.7±5.9 
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Figure S3. Stability of the MTX-nanostars evaluated in the presence of increasing amounts of 
serum for up to 30 days. 
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Figure S4. Quantification of gold accumulated in tissues by ICP-MS. Biodistribution data of 
nanostars and MTX-nanostars in major organs (liver, spleen, lung, intestine, kidney, heart and 
brain) for the healthy mice (A) and lung cancer mice (B) models. The SD (error bars) were 
calculated based on six animals (n = 6) in each study group.  
